v3.25.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2024
Jun. 03, 2024
USD ($)
$ / shares
Award Timing Disclosures [Line Items]    
Award Timing MNPI Disclosure
The Company’s Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information
We do not have any formal policy that requires us to grant, or avoid granting, equity-based compensation to our executive officers at certain times. Consistent with our annual compensation cycle, the Compensation Committee has for several years granted annual equity awards to our executive officers and directors at the start of the new fiscal year. The timing of any equity grants to executive officers in connection with new hires, promotions, or other
non-routine
grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). As a result, in all cases, the timing of grants of equity awards, including stock options, occurs independent of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose of affecting the value of equity-based compensation.
No stock options were issued to executive officers in fiscal year 2024 during any period beginning four business days before the filing of a periodic report or current report disclosing material
non
-
public
information and ending one business day after the filing or furnishing of such report with the SEC, other than as reflected in the table below:
 
Name
   
Grant Date
     
Number of
securities
underlying
the award
     
Exercise
price of
the
award
($/Sh)
     
Grant
Date
fair
value
of the
award
     
Percentage change in
the closing market
price of the securities
underlying the award
between the
trading ending
immediately prior to
the disclosure of
material
nonpublic information
and the trading day
beginning
immediately following
the disclosure of
material nonpublic
information
  
Howard Berman
      06/03/2024        163,663      $ 8.15      $ 6.80        (2.23 %) 
Former Chief Executive Officer, Current Chairman of the Board
               
Fred Grossman
      06/03/2024        70,596      $ 8.15      $ 6.80        (2.23 %) 
President, Chief Medical Officer
               
David Snyder
      06/03/2024        70,596      $ 8.15      $ 6.80        (2.23 %) 
Chief Financial Officer and Chief Operating Officer Arun Swaminathan Chief Executive Officer
(1)
               
 
(1)
Award granted while Dr. Swaminathan served as Chief Business Officer.
 
Award Timing Method The timing of any equity grants to executive officers in connection with new hires, promotions, or other
non-routine
grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). As a result, in all cases, the timing of grants of equity awards, including stock options, occurs independent of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose of affecting the value of equity-based compensation. 		 
Award Timing Predetermined true  
Award Timing, How MNPI Considered The timing of any equity grants to executive officers in connection with new hires, promotions, or other
non-routine
grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). As a result, in all cases, the timing of grants of equity awards, including stock options, occurs independent of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose of affecting the value of equity-based compensation. 		 
MNPI Disclosure Timed for Compensation Value false  
Awards Close in Time to MNPI Disclosures, Table
Name
   
Grant Date
     
Number of
securities
underlying
the award
     
Exercise
price of
the
award
($/Sh)
     
Grant
Date
fair
value
of the
award
     
Percentage change in
the closing market
price of the securities
underlying the award
between the
trading ending
immediately prior to
the disclosure of
material
nonpublic information
and the trading day
beginning
immediately following
the disclosure of
material nonpublic
information
  
Howard Berman
      06/03/2024        163,663      $ 8.15      $ 6.80        (2.23 %) 
Former Chief Executive Officer, Current Chairman of the Board
               
Fred Grossman
      06/03/2024        70,596      $ 8.15      $ 6.80        (2.23 %) 
President, Chief Medical Officer
               
David Snyder
      06/03/2024        70,596      $ 8.15      $ 6.80        (2.23 %) 
Chief Financial Officer and Chief Operating Officer Arun Swaminathan Chief Executive Officer
(1)
               
 
Howard Berman [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Howard Berman
Underlying Securities   163,663
Exercise Price | $ / shares   $ 8.15
Fair Value as of Grant Date   $ 6.8
Underlying Security Market Price Change   (2.23)
Fred Grossman [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Fred Grossman
Underlying Securities   70,596
Exercise Price | $ / shares   $ 8.15
Fair Value as of Grant Date   $ 6.8
Underlying Security Market Price Change   (2.23)
David Snyder [Member]    
Awards Close in Time to MNPI Disclosures    
Name   David Snyder
Underlying Securities   70,596
Exercise Price | $ / shares   $ 8.15
Fair Value as of Grant Date   $ 6.8
Underlying Security Market Price Change   (2.23)